{
    "title": "Individual feed for https://www.medscape.com/cx/rssfeeds/2700.xml",
    "link": "https://www.medscape.com/cx/rssfeeds/2700.xml",
    "description": "Individual feed output.",
    "lastBuildDate": "2025-09-07T22:38:41.825277",
    "items": [
        {
            "title": "First-Line Osimertinib Plus Chemo Extends Survival in NSCLC",
            "link": "https://www.medscape.com/viewarticle/first-line-osimertinib-plus-chemo-extends-survival-nsclc-2025a1000nll?src=rss",
            "description": "The FLAURA2 trial establishes a new standard of care for EGFR-mutated NSCLC, according to the authors of new research. Medscape Medical News",
            "pubDate": "2025-09-08T01:28:36",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture6.png"
        },
        {
            "title": "NSCLC Survival Benefit Seen With EGFR-TKI + Chemo",
            "link": "https://www.medscape.com/viewarticle/nsclc-survival-benefit-seen-egfr-tki-chemo-2025a1000nlj?src=rss",
            "description": "Median PFS benefit was just over 3 months in patients with EGFR-mutant NSCLC who had tumor suppressor gene co-mutations. Medscape Medical News",
            "pubDate": "2025-09-08T00:35:35",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture9.png"
        },
        {
            "title": "Osimertinib's Benefits in NSCLC Can Extend Beyond First Line",
            "link": "https://www.medscape.com/viewarticle/osimertinibs-benefits-nsclc-can-extend-beyond-first-line-2025a1000nlc?src=rss",
            "description": "Patients with EGFR-mutated NSCLC who progress on first-line osimertinib live longer without disease worsening when the drug is maintained alongside ch...",
            "pubDate": "2025-09-07T20:20:16",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture3.png"
        },
        {
            "title": "Perioperative Nivolumab Does Not Sacrifice QoL in NSCLC",
            "link": "https://www.medscape.com/viewarticle/perioperative-nivolumab-does-not-sacrifice-qol-nsclc-2025a1000nl9?src=rss",
            "description": "Perioperative nivolumab in eligible patients with resectable non-small cell lung cancer offers improved survival outcomes and preserves quality of lif...",
            "pubDate": "2025-09-07T16:31:52",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture3.png"
        },
        {
            "title": "Does Eating Red Meat Actually Raise Your Cancer Risk?",
            "link": "https://www.medscape.com/s/viewarticle/does-eating-red-meat-actually-raise-your-cancer-risk-2025a1000nj6?src=rss",
            "description": "Daily processed meat consumption slightly increases colon cancer risk, but occasional consumption is far less concerning than headlines suggest. Medsc...",
            "pubDate": "2025-09-05T18:41:08",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture7.png"
        }
    ]
}